NCT02069041 2018-11-21A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver CancerEli Lilly and CompanyPhase 1 Completed8 enrolled 16 charts
NCT00483405 2017-07-12NRRUNC Lineberger Comprehensive Cancer CenterPhase 2 Completed33 enrolled 14 charts
NCT01229111 2017-03-29Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary CancersNational Cancer Institute (NCI)Phase 2 Terminated14 enrolled 11 charts